FDA approved lowering the age limit to 12 mos for remaining US-licensed hepatitis A vaccine in the US
On Oct. 17, 2005, the FDA approved lowering the age limit to 12 mos for the remaining U.S.-licensed hepatitis A vaccine in the U.S. (Havrix by GlaxoSmithKline).
Tags:
Source: U.S. Centers for Disease Control and Prevention
Credit:
